A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
To compare the difference of a marker of cellular proliferation in all bronchial biopsy
specimens of former smokers stratified by lung cancer risk, collected before and after
treatment per patient between the enzastaurin and placebo groups.